Compounds > arsenic
Page last updated: 2024-08-26

arsenic and Ewing Sarcoma

arsenic has been researched along with Ewing Sarcoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boehme, KA; Handgretinger, R; Kluba, T; Nitsch, J; Riester, R; Schleicher, SB; Traub, F1
Raju, GP1
Albanese, C; Beauchamp, EM; Bulut, G; Hall, MD; Lee, YC; Macdonald, TJ; Ozdemirli, M; Peaceman, D; Ringer, L; Rodriguez, O; Sajwan, KP; Toretsky, JA; Uren, A1
Guo, W; Lu, XC; Ren, TT; Tang, GQ; Zhang, S; Zhao, FL1
Alexander, D; Billups, CA; Houghton, PJ; Kang, MH; Kurmasheva, RT; Reynolds, CP; Smith, MA; Toretsky, JA1
Beauchamp, EM; Uren, A1
Besançon, F; Mathieu, J1
Guo, W; Tang, S; Tang, XD; Yang, Y1
Ahn, HS; Jang, JJ; Jung, HS; Kim, CJ; Kim, HS; Lee, MJ; Ryu, KH; Seoh, JY; Shin, HY1

Reviews

1 review(s) available for arsenic and Ewing Sarcoma

ArticleYear
A new era for an ancient drug: arsenic trioxide and Hedgehog signaling.
    Vitamins and hormones, 2012, Volume: 88

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Leukemia, Promyelocytic, Acute; Medulloblastoma; Oncogene Proteins; Oxides; Sarcoma, Ewing

2012

Other Studies

8 other study(ies) available for arsenic and Ewing Sarcoma

ArticleYear
Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
    International journal of oncology, 2016, Volume: 49, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Bone Neoplasms; Drug Synergism; Etoposide; Flow Cytometry; Humans; Oxides; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; Tumor Cells, Cultured

2016
Arsenic: a potentially useful poison for Hedgehog-driven cancers.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Hedgehog Proteins; Humans; Medulloblastoma; Mice; Models, Biological; Neoplasms; Oxides; Receptors, G-Protein-Coupled; Sarcoma, Ewing; Signal Transduction; Smoothened Receptor; Transcription Factors; Zinc Finger Protein GLI1

2011
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Base Sequence; Cell Line, Tumor; DNA Primers; Gene Expression; Hedgehog Proteins; Hep G2 Cells; Humans; Medulloblastoma; Mice; Mice, SCID; Mice, Transgenic; Neoplasm Transplantation; Oncogene Proteins; Oxides; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Sarcoma, Ewing; Signal Transduction; Smoothened Receptor; Trans-Activators; Transplantation, Heterologous; Zinc Finger Protein GLI1

2011
Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
    Anti-cancer drugs, 2012, Volume: 23, Issue:1

    Topics: Anisomycin; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cytoskeleton; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase Inhibitors; Oxides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Sarcoma, Ewing

2012
Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcoma.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:4

    Topics: Animals; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Cell Line, Tumor; Female; Growth Inhibitors; Mice; Mice, SCID; Oxides; Sarcoma, Ewing; Xenograft Model Antitumor Assays

2012
Clinically tolerable concentrations of arsenic trioxide induce p53-independent cell death and repress NF-kappa B activation in Ewing sarcoma cells.
    International journal of cancer, 2006, Oct-01, Volume: 119, Issue:7

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Line, Tumor; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Mitochondria; NF-kappa B; Oxides; Sarcoma, Ewing; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53

2006
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Jun-15, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Child; Etoposide; Female; Follow-Up Studies; Humans; Male; Osteosarcoma; Oxides; Paclitaxel; Sarcoma, Ewing; Treatment Outcome

2006
Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.
    FEBS letters, 2006, Sep-04, Volume: 580, Issue:20

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Fibroblast Growth Factor 2; Flavonoids; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Neuroblastoma; Neurons; Oxides; Phenotype; Sarcoma, Ewing

2006